Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Gold, Jeremy A.W. ; Adjei, Stacey ; Gundlapalli, Adi V. ; Huang, Ya-Lin A. ; Chiller, Tom ; Benedict, Kaitlin ; Toda, Mitsuru
• Description:
  Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019-2021. During 2020-2021, patients hospitalized with COVID-19-associated fungal infections had higher (48.5%) in-hospital mortality rates than those with non-COVID-19-associated fungal infections (12.3%). Improved fungal disease surveillance is needed, particularly during respiratory virus pandemics.
• Subjects:
  Actinomycosis Aspergillosis Blastomycosis Coccidioidomycosis COVID-19 Cryptococcosis Histoplasmosis Humans Mucormycosis Mycoses Nocardia Infections Pandemics

  More +
• Source:
  Emerg Infect Dis. 2023; 29(7):1433-1437
• Pubmed ID:
  37347805
• Pubmed Central ID:
  PMC10310397
• Document Type:
  Journal Article
• Genre:
  Dispatch
• Place as Subject:
  United States
• Volume:
  29
• Issue:
  7
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:08e9db32d3c19ea4ccda0ebd02658be2f6385408923b0abafc0c00e402216f33
• Download URL:
  https://stacks.cdc.gov/view/cdc/130806/cdc_130806_DS1.pdf
• File Type:
  [PDF - 727.00 KB ]